CTOs on the Move

The Pharma Network

www.thepharmanetwork.com

 
The Pharma Network is a Montvale, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Medcillary

At Medcillary, we provide the latest ancillary products and services that benefit patients and healthcare providers to meet and exceed their unique needs. We are passionate about developing innovative, ground-breaking tests, products and tools to enhance patient care, provide value to our clients, and transform information into knowledge and insights. Our goal is to advance the development and delivery of healthcare and consumer products by providing the highest quality testing possible. Mission: Medcillary was founded with two key principles in place: compliance and clinical relevance with a focus on offering superior and innovative healthcare products aligned to meet the needs of the physicians in our communities, while leading the way for business development and operational excellence through honesty and integrity with our strategic partners. Our vision is to be the most successful and respected medical ancillary solution company in the world. Our core values are: - Commitment - Integrity - Transparency - Pursuit of Excellence - Customer Focus - Respect

Ride Away Equipment Corp

Here at Ride Away, we offer a competitive benefits package for you and your loved ones. Here is a list of the benefits that Ride Away currently offers: Medical/Dental Insurance Vision Insurance Flex Spending Account (both medical and dependent care)

Xradia

Xradia designs and manufactures a suite of ultra high resolution 3D x-ray microscopes and fluorescence imaging systems for non-destructive imaging of embedded internal structures.

Portola

Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.

Oasis Marketing Partners

Oasis Marketing Partners is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.